Prudential PLC Reduces Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

Prudential PLC cut its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 67.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 13,945 shares of the company's stock after selling 29,024 shares during the period. Prudential PLC's holdings in HealthEquity were worth $1,338,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of HQY. Arcadia Investment Management Corp MI bought a new stake in HealthEquity during the 4th quarter valued at $26,000. Smartleaf Asset Management LLC boosted its position in HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after purchasing an additional 98 shares in the last quarter. Proficio Capital Partners LLC purchased a new position in HealthEquity in the fourth quarter valued at about $39,000. UMB Bank n.a. raised its holdings in HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company's stock worth $40,000 after purchasing an additional 164 shares in the last quarter. Finally, Skandinaviska Enskilda Banken AB publ lifted its position in shares of HealthEquity by 1,934.8% during the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company's stock valued at $45,000 after buying an additional 445 shares during the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts recently commented on HQY shares. The Goldman Sachs Group reduced their price objective on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research note on Thursday, March 27th. Raymond James raised HealthEquity from an "outperform" rating to a "strong-buy" rating and reduced their price target for the stock from $120.00 to $115.00 in a research report on Tuesday, March 25th. Wells Fargo & Company raised their price objective on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 26th. KeyCorp reduced their target price on HealthEquity from $120.00 to $110.00 and set an "overweight" rating on the stock in a research report on Monday, March 24th. Finally, Barrington Research reissued an "outperform" rating and issued a $112.00 price target on shares of HealthEquity in a report on Friday. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, HealthEquity currently has an average rating of "Buy" and an average price target of $112.58.

Remove Ads

Insiders Place Their Bets

In other HealthEquity news, EVP Michael Henry Fiore sold 8,881 shares of the firm's stock in a transaction on Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the transaction, the executive vice president now owns 56,655 shares in the company, valued at approximately $4,433,820.30. This trade represents a 13.55 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Robert W. Selander sold 5,750 shares of the company's stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now directly owns 78,219 shares of the company's stock, valued at $8,704,992.51. The trade was a 6.85 % decrease in their position. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by company insiders.

HealthEquity Price Performance

Shares of HealthEquity stock traded down $0.39 during trading hours on Friday, reaching $79.55. The stock had a trading volume of 190,091 shares, compared to its average volume of 756,376. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $6.88 billion, a PE ratio of 72.89, a PEG ratio of 1.60 and a beta of 0.49. The stock's 50 day moving average is $98.22 and its 200 day moving average is $96.27.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.